ORYZON reports financial results and corporate update for quarter ended December 31st, 202... 02/03/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Financing Strong cash position at year-end 2025: $33.3 million (€28.4 million). Partners - Oryzon Genomics
Genetics drives a new stage in precision preventive medicine 03/03/2026 Healthcare Personalized medicine The integration of polygenic risk models based on genome-wide association studies (GWAS) enables healthcare... Partners - ADNTRO GENETICS SL
The impact of digital twins on personalised medicine 20/02/2026 Healthcare Personalized medicine Digital twins make it possible to simulate personalised clinical scenarios without intervening directly on the patient... Partners - GENESIS Biomed
Childhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera... 15/02/2026 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Marina Salmón, Head of Project Evaluation at the Scientific Foundation of the Spanish Association Against Cancer, a... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Childhood Cancer Needs Greater Awareness and Stable Funding to Accelerate Innovative Thera... 15/02/2026 Fundación Científica de la Asociación Española Contra el Cáncer In Spain, around 1,500 cases of childhood cancer are diagnosed each year (1% of the total), making research more... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Biotechnology in the fight against cancer: from smart vectors to protein disorder as a the... 04/02/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and... AseBio
Biotechnology in the fight against cancer: from smart vectors to protein disorder as a the... 04/02/2026 Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and... AseBio
When genetics does not change, but science does. The challenge of keeping genetic health i... 02/02/2026 Healthcare Personalized medicine A person's genetics do not change throughout their life. What does change, and does so constantly, is the scientific... Partners - ADNTRO GENETICS SL
The 4th AseBio – TERAV – CIBER Forum examines how to boost value chains in advanced therap... 14/01/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Advanced therapies offer new therapeutic options for complex diseases and also represent a strategic asset due to their... AseBio
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies On World Cancer Research Day, the AECC Scientific Foundation reminds us that only through the joint commitment of... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
